FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, particularly to a heterocyclic compound of formula I or a pharmaceutically acceptable salt thereof, wherein A is pyridyl substituted with one or two A'; each A' is independently C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, pyrrolidinyl, piperidinyl optionally substituted with one or two C1-6 alkyls; n is 0 or 1; B is phenyl; each R is independently -C(=O)R1, -C(=O)OR1 or -C(=O)NHR1; R1 is H or R1'; R1' is C1-6 alkyl, phenyl, indolyl, indazolyl, pyridinyl C1-6 alkyl or morpholinyl optionally substituted with one or two ; each is hydroxy, C1-6 alkyl, C1-6 alkoxy, carboxy or oxo. Specific derivatives of imidazo[1,2-b]pyridazine are also described.
I.
EFFECT: technical result is obtaining novel heterocyclic compounds useful as inhibitors of SYK.
8 cl, 1 tbl, 96 ex
Title | Year | Author | Number |
---|---|---|---|
THIAZOLPYRIMIDINES | 2012 |
|
RU2610840C2 |
IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2014 |
|
RU2618529C2 |
TRIAZOLO-PYRIMIDINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2802866C2 |
BICYCLIC PIPERAZINE COMPOUNDS | 2012 |
|
RU2628616C2 |
MACROCYCLIC TYROSINE KINASE INHIBITOR AND ITS USE | 2019 |
|
RU2798231C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
PYRAZINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2809631C2 |
MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
CXCR7 ANTAGONISTS | 2013 |
|
RU2649004C2 |
Authors
Dates
2018-07-26—Published
2012-10-29—Filed